По вашему запросу найдено документов: 259

Страница 1 из 26

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
-emergent adverse event was anaemia or decreased haemoglobin (in 52 [22%] of 232 patients in the rucaparib group vs
MicroRNAs as prognostic markers and therapeutic targets in gliomas
Sufianov, A., Begliarzade, S., Ilyasova, T., Liang, Y., Beylerli, O. (2022)
be used for diagnosis and prognosis, including the response of a particular patient to therapy
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Onorato, Eustaquio Maria, Onorato, Eustaquio Maria, Muratori, Manuela, Smolka, Grzegorz, Wojakowski, Wojtek, Pysz, Piotr, Zorinas, Aleksejus, Zakarkaite, Diana, Eltchaninoff, Hélène, Litzer, Pierre-Yves, Godart, François, Calvert, Patrick, Christou, Christos, Mussayev, Abdurashid, Missiroli, Bindo, Buzaev, Igor, Curello, Salvatore, Tesorio, Tullio, Bartorelli, Antonio Luca (2022)
PVLs. The full analysis set (FAS) comprised 112 patients with available stratum (aortic/mitral leak
Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
Onorato, EM, Alamanni, F, Muratori, M, Smolka, G, Wojakowski, W, Pysz, P, Zorinas, A, Zakarkaite, D, Eltchaninoff, H, Litzer, PY, Godart, F, Calvert, P, Christou, C, Mussayev, A, Missiroli, B, Buzaev, I, Curello, S, Tesorio, T, Bartorelli, AL (2022)
PVLs. The full analysis set (FAS) comprised 112 patients with available stratum (aortic/mitral leak
ПРИМЕНЕНИЕ ГИБРИДНОГО ХИРУРГИЧЕСКОГО МЕТОДА В ЛЕЧЕНИИ ОСТРОГО ДЕСТРУКТИВНОГО ПИЕЛОНЕФРИТА
THE USE OF A HYBRID SURGICAL METHOD IN THE TREATMENT OF DESTRUCTIVE PYELONEPHRITIS
Ананьев, В.А., Павлов, В.Н., Пушкарёв, А.М., Ananev, V.A., Pavlov, V.N., Pushkarev, A.M. (2022)
of treating patient K. 18 years old, with a diagnosis of destructive pyelonephritis on the right on the basis
Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis
Yanchao, L., Sibin, Z., Gareev, I., Huan, X., Junfei, Z., Chunyang, L., Beylerli, O., Sufianov, A., Chao, Y., Yuyan, G., Xun, X., Ahmad, A. (2022)
with several ailments and conditions, including IS and carotid atherosclerosis. More patient-based data-sets
Синдром Николау: некротическая активность лекарств и способы предотвращения постинъекционных абсцессов (в память о профессоре Ласло Гемзе)
Nikolau Syndrome: Necrotic Activity of Drugs and Ways to Prevent Post-Injection Abscesses (In memory of Professor László A Gömze)
А. Л. Ураков, A. L. Urakov (Креативная хирургия и онкология, №2, 2022)
Nikolau Syndrome: Necrotic Activity of Drugs and Ways to Prevent Post-Injection Abscesses (In
Резолюция Совета экспертов «Дисбиоз. Ближайшие и отдаленные последствия нарушения микробиома и варианты их коррекции с помощью пробиотиков»
Resolution of the Council of Experts “Dysbiosis. Immediate and long-term consequences of microbiome disorders and options for their correction with probiotics”
Gorelov, A.V., Zakharova, I.N., Khavkin, A.I., Kafarskaya, L.I., Usenko, D.V., Belmer, S.V., Kornienko, E.A., Privorotsky, V.F., Krasnov, V.V., Kondyurina, E.G., Panfilova, V.N., Tkhakushinova, N.Kh., Plaksina, A.N., Rychkova, O.A., Pechkurov, D.V., Nizhevich, A.A., Fayzullina, R.A., Yablokova, E.A., А.В.Горелов, И.Н.Захарова, А.И.Хавкин, Л.И.Кафарская, Д.В.Усенко, С.В.Бельмер, Е.А.Корниенко, В.Ф.Приворотский, В.В.Краснов, Е.Г.Кондюрина, В.Н.Панфилова, Н.Х.Тхакушинова, А.Н.Плаксина, О.А.Рычкова, Д.В.Печкуров, А.А.Нижевич, Р.А.Файзуллина, Е.А.Яблокова (2022)
" for the intestinal microbiome have not been definitively established. To study the microbiome, a set of methods
Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
Wu, JN, Al-Zahrani, A, Beylerli, O, Sufianov, R, Talybov, R, Meshcheryakova, S, Sufianova, G, Gareev, I, Sufianov, A (2022)
Central Register of Controlled Trials, and Web of Science database and obtained different sets of data
Counseling about sudden unexpected death in epilepsy (SUDEP): A global survey of neurologists' opinions
Asadi-Pooya, AA, Trinka, E, Brigo, F, Hingray, C, Karakis, I, Lattanzi, S, Valente, KD, Contreras, G, Turuspekova, ST, Kishk, NA, Aljandeel, G, Farazdaghi, M, Lopez, YC, Kissani, N, Triki, C, Kramer, G, Surges, R, Mesraoua, B, Yu, HY, Daza-Restrepo, A, Alsaadi, T, Al-Asmi, A, Kutlubaev, MA, Pretorius, C, Jusupova, A, Khachatryan, SG, Ranganathan, LN, Ashkanani, A, Tomson, T, Gigineishvili, D (2022)
countries participated; 41.5% of the respondents reported they discuss the risk of SUDEP with patients

Страница 1 из 26

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год